Safety and effectiveness of nafamostat mesylate in continuous renal replacement therapy in patients with sepsis-associated acute kidney injury: a prospective randomized controlled trial
To determine the safety and effectiveness of the anticoagulation regimen nafamostat mesylate for continuous renal replacement therapy in patients with sepsis-associated AKI.
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
De Gruyter
2026-02-01
|
| Seria: | Open Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1515/med-2025-1369 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|